- ‘Silent’ COVID-19 Produces as Much Virus as in Patients With Symptoms: Study
- Immune System Clues to Why COVID Is Easier on Kids
- Is Shock Therapy Making a Comeback Against Bipolar Disorder?
- Conspiracy Theories Are Helping Fuel Rejection of Masks, Vaccines
- U.S. Coronavirus Cases Top 7 Million
- Health Highlights: Sept. 25, 2020
- After COVID-19 Exposure, When Can Young Athletes Resume Play?
- Kids Who Need Steroids Face Risk of Diabetes, Other Ills
- COVID Bites: Cracked Teeth Another Coronavirus Scourge
- Americans Are Cutting Back on Sugary Drinks
Clinical Trials Update: Aug. 2, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Diabetic Peripheral Neuropathy (DPN)
If you or a loved one has pain, tingling, numbness or loss of feeling in your legs or feet caused by diabetes, you may qualify for this study.
The research site is in Idaho Falls, Idaho.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.
—–
Overactive Bladder (OAB)
This study of an FDA-approved medication is for people 65 or older who have symptoms of overactive bladder.
The research site is in St. Louis, Mo.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/overactive_bladder.aspx.
—–
Gout
This study will compare an investigational drug in combination with allopurinol versus allopurinol alone to treat gout. Study participants must be aged 18 to 80 and be taking at least 300 mg. of allopurinol daily.
The research site is in Cleveland, Ohio.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
